Assort Health picked up $120 million in series C funding, hitting unicorn status, to fuel the company's work building out a voice AI agent platform for healthcare. Menlo Ventures led the round, and the series C also was backed by Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures and Quiet Capital. “The healthcare system has historically had so many antiquated and inefficient processes that are finally being transformed with agentic platforms. Assort ...